A rapid and novel quantitative determination of Lecanemab monoclonal antibody for Alzheimer’s disease using reverse phase ultra performance liquid chromatography-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A rapid and novel quantitative determination of Lecanemab monoclonal antibody for Alzheimer’s disease using reverse phase ultra performance liquid chromatography

Published:2024-07-03 Issue:4 Volume:14 Page:446-457
ISSN:2229-7928
Container-title:Analytical Chemistry Letters
language:en
Short-container-title:Analytical Chemistry Letters

Author:

Neeladhri Karuna Kumari¹,Sailaja B.B.V.²,Pallapati Suman³

Affiliation:

1. Department of chemistry, Andhra University, Visakhapatnam, Andhra Pradesh, 530003, India and Dr Reddy’s Labs, Hyderabad, Telangana, India

2. Department of chemistry, Andhra University, Visakhapatnam, Andhra Pradesh, 530003, India

3. Department of chemistry, Andhra University, Visakhapatnam, Andhra Pradesh, 530003, India and Laurus Labs Ltd, Visakhapatnam, Andhra Pradesh, India.

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/22297928.2024.2397799

Reference23 articles.

1. The amyloid hypothesis of Alzheimer's disease at 25 years

2. Lecanemab Summary Review” . Center for Drug Evaluation and Research (CDER). U.S. Food and Drug Administration (FDA). Archived from the original on 7 January 2023. Retrieved 7 January 2023.

3. Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer’s disease: A systematic review

4. Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease

5. Soluble Amyloid-beta Aggregates from Human Alzheimer’s Disease Brains

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP